Will sales of ‘Enbrel’ increase by the launch of its biosimilar?
The launch of biosimilar ‘Brenzys’ decreased the health insurance benefit of ‘Enbrel’ by 30%, enlarging the price competition against Enbrel. Their prescriptions will be increased jointly through the effect of the launch and the ‘cost-effectiveness’ of Enbrel.
From February of this year, the En...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
